Jane Street’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Jane Street’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-20,077	Closed	-$6.63K	–	9961
2023 Q1	$6.63K	Buy	20,077 +3,755	+23%	+$3.47K	﹤0.01%	8786
2022 Q4	$11.8K	Buy	+16,322	New	+$16.2K	﹤0.01%	8737
2019 Q3	–	Sell	-24,178	Closed	-$411K	–	5957
2019 Q2	$411K	Buy	+24,178	New	+$654K	﹤0.01%	3824
2019 Q1	–	Sell	-1,632	Closed	-$48K	–	5835
2018 Q4	$48K	Buy	+1,632	New	+$72.4K	﹤0.01%	4733
2017 Q4	–	Sell	-1,912	Closed	-$221K	–	5333
2017 Q3	$221K	Buy	1,912 +478	+33%	+$50.3K	﹤0.01%	4030
2017 Q2	$167K	Buy	+1,434	New	+$178K	﹤0.01%	4077
2017 Q1	–	Sell	-1,064	Closed	-$145K	–	4831
2016 Q4	$145K	Buy	+1,064	New	+$189K	﹤0.01%	3811
2016 Q2	–	Sell	-1,256	Closed	-$117K	–	4735
2016 Q1	$117K	Buy	+1,256	New	+$137K	﹤0.01%	3852
2015 Q1	–	Sell	-6,022	Closed	-$1.39M	–	3579
2014 Q4	$1.39M	Buy	+6,022	New	+$1.29M	0.01%	845

Other funds holding BLCM

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

PGAM

Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return

Jane Street's BLCM Position: Q2 2023 in Review

Jane Street sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q2 2023, closing a stake of 20,077 shares — an estimated $6.63K sold.

Jane Street first reported a position in BLCM in Q4 2014 and held it in 9 quarters. The position peaked at $1.39M in Q4 2014. 4 funds tracked by Wall St. Rank hold BLCM as of Q2 2023.

Jane Street reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
Jane Street sold 20,077 Bellicum Pharmaceuticals, Inc. shares in Q2 2023, an estimated $6.63K.
Jane Street first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2014 and held it in 9 quarters.
Jane Street's Bellicum Pharmaceuticals, Inc. position peaked at $1.39M in Q4 2014.
4 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q2 2023.

Based on Jane Street's 13F filing for Q2 2023, filed 14 Aug 2023.